Most-Used ARV Regimen in South Africa May Yield Poorest Survival

Of five first-line antiretroviral (ARV) regimens considered in a South African modeling study, the one used most today—stavudine, lamivudine, and nevirapine—yielded the poorest quality-adjusted survival and cost more (in a cost-effectiveness analysis) than combined zidovudine, lamivudine, and nevirapine.

The World Health Organization (WHO) recommends four first-line regimens for resource-limited settings. WHO no longer recommends stavudine, lamivudine, and nevirapine, but that combination remains the most popular because of availability in a fixed-dose combination and a low wholesale cost. But the relative cost-effectiveness of these five regimens was not known until US researchers compared the five antiretroviral combinations.

Full Story and Study Abstract:


Leave a comment

Filed under community development, Education, Health, South African Government

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s